Skip to main content
Top
Published in: Calcified Tissue International 2/2003

01-08-2003 | Controversies and Coutnerpoints

Inflammatory Mediators as Essential Elements in Bone Remodeling

Author: S. R. Goldring

Published in: Calcified Tissue International | Issue 2/2003

Login to get access

Abstract

Inflammatory disorders such as rheumatoid arthritis (RA), may have profound effects on skeletal homeostasis. In contrast to physiologic remodeling in which mechanical influences and/or systemic endocrine hormones initiate the remodeling process, in disorders such as RA the recruitment of macrophage lineage cells to sites of inflammation and the action of local osteoclastogenic cytokines associated with the inflammatory process initiate the remodeling process. In both physiologic and pathologic remodeling, osteoclasts appear to be the principal cell type responsible for the bone resorption. In addition, many of the same cytokines and mediators are involved in physiologic and pathologic bone remodeling. These observations have important implications with respect to the development of therapeutic strategies to prevent bone loss in inflammatory conditions.
Literature
2.
go back to reference Parfitt, AM 2002Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression.Bone3057CrossRefPubMed Parfitt, AM 2002Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression.Bone3057CrossRefPubMed
3.
go back to reference Parfitt, A 2001Targeted and non-targeted bone remodeling: relationship to BMU origination and progression.Bone30585587 Parfitt, A 2001Targeted and non-targeted bone remodeling: relationship to BMU origination and progression.Bone30585587
5.
go back to reference Hofbauer, LC, Khosla, S, Dunstan, CR, et al. 2000The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.J Bone Miner Res15212PubMed Hofbauer, LC, Khosla, S, Dunstan, CR,  et al. 2000The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.J Bone Miner Res15212PubMed
6.
go back to reference Suda, T, Takahashi, N, Udagawa, N, et al. 1999Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.Endocr Rev20345357PubMed Suda, T, Takahashi, N, Udagawa, N,  et al. 1999Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.Endocr Rev20345357PubMed
8.
go back to reference Goldring, SR, Gravallese, EM 2000Pathogenesis of bone erosions in rheumatoid arthritis.Curr Opin Rheumatol12195199CrossRefPubMed Goldring, SR, Gravallese, EM 2000Pathogenesis of bone erosions in rheumatoid arthritis.Curr Opin Rheumatol12195199CrossRefPubMed
9.
go back to reference Simonet, WS, Lacey, DL, Dunstan, CR, et al. 1997Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.Cell89309319PubMed Simonet, WS, Lacey, DL, Dunstan, CR,  et al. 1997Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.Cell89309319PubMed
10.
go back to reference Romas, E, Gillespie, M, Martin, T 2002Involvement of receptor activator of NF-κβ ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis.Bone30340346CrossRefPubMed Romas, E, Gillespie, M, Martin, T 2002Involvement of receptor activator of NF-κβ ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis.Bone30340346CrossRefPubMed
11.
go back to reference Kanzaki, H, Chiba, M, Shimizu, Y, et al. 2002Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via PGE2 synthesis.J Bone Miner Res17210220PubMed Kanzaki, H, Chiba, M, Shimizu, Y,  et al. 2002Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via PGE2 synthesis.J Bone Miner Res17210220PubMed
12.
go back to reference Bateman, T, Dunstan, C, Ferguson, V, et al. 2000Osteoprotegerin mitigates tail suspension-induced osteopenia.Bone26443449PubMed Bateman, T, Dunstan, C, Ferguson, V,  et al. 2000Osteoprotegerin mitigates tail suspension-induced osteopenia.Bone26443449PubMed
13.
go back to reference Kobayashi, Y, Hashimoto, F, Miyamoto, H, et al. 2000Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.J Bone Miner Res1519241934PubMed Kobayashi, Y, Hashimoto, F, Miyamoto, H,  et al. 2000Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.J Bone Miner Res1519241934PubMed
14.
go back to reference Goldring, SR, Gravallese, EM 2000Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Arthritis Res23337CrossRefPubMed Goldring, SR, Gravallese, EM 2000Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Arthritis Res23337CrossRefPubMed
15.
go back to reference Gravallese, EM, Manning, C, Tsay, A, et al. 2000Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum43250258PubMed Gravallese, EM, Manning, C, Tsay, A,  et al. 2000Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum43250258PubMed
16.
go back to reference Haynes, DR, Crotti, TN, Loric, M, et al. 2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.Rheumatology (Oxford)40623630CrossRef Haynes, DR, Crotti, TN, Loric, M,  et al. 2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.Rheumatology (Oxford)40623630CrossRef
17.
go back to reference Kuratani, T, Nagata, K, Kukita, T, et al. 1998Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover.Histol Histopathol13751759PubMed Kuratani, T, Nagata, K, Kukita, T,  et al. 1998Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover.Histol Histopathol13751759PubMed
18.
go back to reference Romas, E, Bakharevski, O, Hards, DK, et al. 2000Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis.Arthritis Rheum43821826PubMed Romas, E, Bakharevski, O, Hards, DK,  et al. 2000Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis.Arthritis Rheum43821826PubMed
19.
go back to reference Suzuki, Y, Nishikaku, F, Nakatuka, M, et al. 1998Osteoclast-like cells in murine collagen-induced arthritis.J Rheumatol2511541160PubMed Suzuki, Y, Nishikaku, F, Nakatuka, M,  et al. 1998Osteoclast-like cells in murine collagen-induced arthritis.J Rheumatol2511541160PubMed
20.
go back to reference Fujikawa, Y, Shingu, M, Torisu, T, et al. 1996Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium.Br J Rheumatol35213217PubMed Fujikawa, Y, Shingu, M, Torisu, T,  et al. 1996Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium.Br J Rheumatol35213217PubMed
21.
go back to reference Chang, JS, Quinn, JM, Demaziere, A, et al. 1992Bone resorption by cells isolated from rheumatoid synovium.Ann Rheum Dis512231229 Chang, JS, Quinn, JM, Demaziere, A,  et al. 1992Bone resorption by cells isolated from rheumatoid synovium.Ann Rheum Dis512231229
22.
go back to reference Suzuki, Y, Tsutsumi, Y, Nakagawa, M, et al. 2001Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium.Rheumatology (Oxford)40673682CrossRef Suzuki, Y, Tsutsumi, Y, Nakagawa, M,  et al. 2001Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium.Rheumatology (Oxford)40673682CrossRef
23.
go back to reference Pettit, A, Hong, J, von Stechow, D, et al. 2001TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.Am J Pathol15916891699PubMed Pettit, A, Hong, J, von Stechow, D,  et al. 2001TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.Am J Pathol15916891699PubMed
24.
go back to reference Redlich, K, Hayer, S, Maier, A, et al. 2002Tumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.Arthritis Rheum46785792CrossRefPubMed Redlich, K, Hayer, S, Maier, A,  et al. 2002Tumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.Arthritis Rheum46785792CrossRefPubMed
25.
go back to reference Kong, YY, Feige, U, Sarosi, I, et al. 1999Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.Nature402304309PubMed Kong, YY, Feige, U, Sarosi, I,  et al. 1999Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.Nature402304309PubMed
26.
go back to reference Horwood, NJ, Kartsogiannis, V, Quinn, JMW, et al. 1999Activated T lymphocytes support osteoclast formation in vitro.Biochem Biophys Res Commun265144150CrossRefPubMed Horwood, NJ, Kartsogiannis, V, Quinn, JMW,  et al. 1999Activated T lymphocytes support osteoclast formation in vitro.Biochem Biophys Res Commun265144150CrossRefPubMed
27.
go back to reference Takayanagi, H, Iizuka, H, Juji, T, et al. 2000Involvement of receptor activator of nuclear factor kappa-β ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.Arthritis Rheum43259269PubMed Takayanagi, H, Iizuka, H, Juji, T,  et al. 2000Involvement of receptor activator of nuclear factor kappa-β ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.Arthritis Rheum43259269PubMed
28.
go back to reference Tsuboi, M, Kawakami, A, Nakashima, T, et al. 1999Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts.J Lab Clin Med134190191PubMed Tsuboi, M, Kawakami, A, Nakashima, T,  et al. 1999Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts.J Lab Clin Med134190191PubMed
29.
go back to reference Chen, S, Guttridge, D, Tang, E, et al. 2001Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaβ-independent bone morphogenetic protein/Smad signaling.J Biol Chem2763925939263CrossRefPubMed Chen, S, Guttridge, D, Tang, E,  et al. 2001Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaβ-independent bone morphogenetic protein/Smad signaling.J Biol Chem2763925939263CrossRefPubMed
30.
go back to reference Shimizu, S, Shiozawa, S, Shiozawa, K, et al. 1985Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis.Arthritis Rheum282531PubMed Shimizu, S, Shiozawa, S, Shiozawa, K,  et al. 1985Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis.Arthritis Rheum282531PubMed
31.
go back to reference Bromley, M, Woolley, DE 1984Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion.Arthritis Rheum27857863PubMed Bromley, M, Woolley, DE 1984Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion.Arthritis Rheum27857863PubMed
32.
go back to reference Goldring, SR 1996Osteoporosis and rheumatic diseases.Favus, MJ eds. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed.Lippincott-RavenPhiladelphia299301 Goldring, SR 1996Osteoporosis and rheumatic diseases.Favus, MJ eds. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed.Lippincott-RavenPhiladelphia299301
33.
go back to reference Goldring, SR, Polisson, RP 1998Bone disease in rheumatological disorders.Avioli, LKrane, SM eds. Metabolic bone disease, 2nd ed.Academic PressSan Diego621635 Goldring, SR, Polisson, RP 1998Bone disease in rheumatological disorders.Avioli, LKrane, SM eds. Metabolic bone disease, 2nd ed.Academic PressSan Diego621635
34.
go back to reference Saag, K, Rochelle, K, Caldwell, J, et al. 1994Low-dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.Am J Med96115123PubMed Saag, K, Rochelle, K, Caldwell, J,  et al. 1994Low-dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.Am J Med96115123PubMed
Metadata
Title
Inflammatory Mediators as Essential Elements in Bone Remodeling
Author
S. R. Goldring
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 2/2003
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-002-1049-y

Other articles of this Issue 2/2003

Calcified Tissue International 2/2003 Go to the issue